BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38111038)

  • 1. Quantitative thresholds for variant enrichment in 13,845 cases: improving pathogenicity classification in genetic hearing loss.
    Liu S; Zhong M; Huang Y; Zhang Q; Chen T; Xu X; Peng W; Wang X; Feng X; Kang L; Lu Y; Cheng J; Bu F; Yuan H
    Genome Med; 2023 Dec; 15(1):116. PubMed ID: 38111038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines.
    Fortuno C; Michailidou K; Parsons M; Dolinsky JS; Pesaran T; Yussuf A; Mester JL; Hruska KS; Hiraki S; O'Connor R; Chan RC; Kim S; Tavtigian SV; Goldgar D; James PA; Spurdle AB
    Hum Mol Genet; 2024 Apr; 33(8):724-732. PubMed ID: 38271184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
    Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
    Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.
    Oza AM; DiStefano MT; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Murry JB; Hasadsri L; Nara K; Kenna M; Booth KT; Azaiez H; Griffith A; Avraham KB; Kremer H; Rehm HL; Amr SS; Abou Tayoun AN;
    Hum Mutat; 2018 Nov; 39(11):1593-1613. PubMed ID: 30311386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP-HL: Semi-automated ACMG/AMP variant interpretation platform for genetic hearing loss.
    Peng J; Xiang J; Jin X; Meng J; Song N; Chen L; Abou Tayoun A; Peng Z
    Hum Mutat; 2021 Dec; 42(12):1567-1575. PubMed ID: 34428318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving genetic diagnosis by disease-specific, ACMG/AMP variant interpretation guidelines for hearing loss.
    Kim SY; Kim BJ; Oh DY; Han JH; Yi N; Kim NJ; Park MK; Keum C; Seo GH; Choi BY
    Sci Rep; 2022 Jul; 12(1):12457. PubMed ID: 35864128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The updates of the ACMG variant interpretation guidelines affect the pathogenicity determination of
    Wu KL; Li J; Wang HY; Wang QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 59(5):455-463. PubMed ID: 38811176
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the impact of in silico predictors on clinical variant classification.
    Wilcox EH; Sarmady M; Wulf B; Wright MW; Rehm HL; Biesecker LG; Abou Tayoun AN
    Genet Med; 2022 Apr; 24(4):924-930. PubMed ID: 34955381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GenOtoScope: Towards automating ACMG classification of variants associated with congenital hearing loss.
    Melidis DP; Landgraf C; Schmidt G; Schöner-Heinisch A; von Hardenberg S; Lesinski-Schiedat A; Nejdl W; Auber B
    PLoS Comput Biol; 2022 Sep; 18(9):e1009785. PubMed ID: 36129964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants.
    Patel RY; Shah N; Jackson AR; Ghosh R; Pawliczek P; Paithankar S; Baker A; Riehle K; Chen H; Milosavljevic S; Bizon C; Rynearson S; Nelson T; Jarvik GP; Rehm HL; Harrison SM; Azzariti D; Powell B; Babb L; Plon SE; Milosavljevic A;
    Genome Med; 2017 Jan; 9(1):3. PubMed ID: 28081714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls.
    Walsh R; Lahrouchi N; Tadros R; Kyndt F; Glinge C; Postema PG; Amin AS; Nannenberg EA; Ware JS; Whiffin N; Mazzarotto F; Škorić-Milosavljević D; Krijger C; Arbelo E; Babuty D; Barajas-Martinez H; Beckmann BM; Bézieau S; Bos JM; Breckpot J; Campuzano O; Castelletti S; Celen C; Clauss S; Corveleyn A; Crotti L; Dagradi F; de Asmundis C; Denjoy I; Dittmann S; Ellinor PT; Ortuño CG; Giustetto C; Gourraud JB; Hazeki D; Horie M; Ishikawa T; Itoh H; Kaneko Y; Kanters JK; Kimoto H; Kotta MC; Krapels IPC; Kurabayashi M; Lazarte J; Leenhardt A; Loeys BL; Lundin C; Makiyama T; Mansourati J; Martins RP; Mazzanti A; Mörner S; Napolitano C; Ohkubo K; Papadakis M; Rudic B; Molina MS; Sacher F; Sahin H; Sarquella-Brugada G; Sebastiano R; Sharma S; Sheppard MN; Shimamoto K; Shoemaker MB; Stallmeyer B; Steinfurt J; Tanaka Y; Tester DJ; Usuda K; van der Zwaag PA; Van Dooren S; Van Laer L; Winbo A; Winkel BG; Yamagata K; Zumhagen S; Volders PGA; Lubitz SA; Antzelevitch C; Platonov PG; Odening KE; Roden DM; Roberts JD; Skinner JR; Tfelt-Hansen J; van den Berg MP; Olesen MS; Lambiase PD; Borggrefe M; Hayashi K; Rydberg A; Nakajima T; Yoshinaga M; Saenen JB; Kääb S; Brugada P; Robyns T; Giachino DF; Ackerman MJ; Brugada R; Brugada J; Gimeno JR; Hasdemir C; Guicheney P; Priori SG; Schulze-Bahr E; Makita N; Schwartz PJ; Shimizu W; Aiba T; Schott JJ; Redon R; Ohno S; Probst V; ; Behr ER; Barc J; Bezzina CR
    Genet Med; 2021 Jan; 23(1):47-58. PubMed ID: 32893267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
    Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
    J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
    Pejaver V; Byrne AB; Feng BJ; Pagel KA; Mooney SD; Karchin R; O'Donnell-Luria A; Harrison SM; Tavtigian SV; Greenblatt MS; Biesecker LG; Radivojac P; Brenner SE;
    Am J Hum Genet; 2022 Dec; 109(12):2163-2177. PubMed ID: 36413997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of gene variants linked to hearing loss based on allele frequency threshold and filtering allele frequency.
    Rim JH; Lee JS; Jung J; Lee JH; Lee ST; Choi JR; Choi JY; Lee MG; Gee HY
    Sci Rep; 2019 Mar; 9(1):4583. PubMed ID: 30872718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.
    Gelb BD; Cavé H; Dillon MW; Gripp KW; Lee JA; Mason-Suares H; Rauen KA; Williams B; Zenker M; Vincent LM;
    Genet Med; 2018 Nov; 20(11):1334-1345. PubMed ID: 29493581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification.
    Chora JR; Iacocca MA; Tichý L; Wand H; Kurtz CL; Zimmermann H; Leon A; Williams M; Humphries SE; Hooper AJ; Trinder M; Brunham LR; Costa Pereira A; Jannes CE; Chen M; Chonis J; Wang J; Kim S; Johnston T; Soucek P; Kramarek M; Leigh SE; Carrié A; Sijbrands EJ; Hegele RA; Freiberger T; Knowles JW; Bourbon M;
    Genet Med; 2022 Feb; 24(2):293-306. PubMed ID: 34906454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.
    Johnston JJ; Dirksen RT; Girard T; Gonsalves SG; Hopkins PM; Riazi S; Saddic LA; Sambuughin N; Saxena R; Stowell K; Weber J; Rosenberg H; Biesecker LG
    Genet Med; 2021 Jul; 23(7):1288-1295. PubMed ID: 33767344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding ACMG variant classification guidelines into a general framework.
    Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
    Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.
    Tavtigian SV; Harrison SM; Boucher KM; Biesecker LG
    Hum Mutat; 2020 Oct; 41(10):1734-1737. PubMed ID: 32720330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.